Multimodality therapy for advanced or metastatic sarcoma

This publication has 113 references indexed in Scilit:

• A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases
  Radiation Oncology, 2012
• A retrospective study of SBRT of metastases in patients with primary sarcoma
  Medical Oncology, 2012
• Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor
  Cancer, 2011
• Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus‐associated Kaposi sarcoma
  Cancer, 2010
• Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas
  European Journal of Cancer, 2010
• KDR Activating Mutations in Human Angiosarcomas Are Sensitive to Specific Kinase Inhibitors
  Cancer Research, 2009
• Antivascular Actions of Microtubule-Binding Drugs
  Clinical Cancer Research, 2009
• Phase III trial of standard versus dose-intensified doxorubicin, ifosfamide and dacarbazine (MAID) in the first-line treatment of metastatic and locally advanced soft tissue sarcoma
  Investigational New Drugs, 2009
• Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II trial
  Gynecologic Oncology, 2008
• Phase II studies of docetaxel in the treatment of various solid tumours
  European Journal of Cancer, 1995